We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Semaglutide was tied to nonarteritic anterior ischemic ...
Please provide your email address to receive an email when new articles are posted on . Semaglutide was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy — a form ...
To test whether Heidelberg Retina Tomograph (HRT) is applicable to assess the optic nerve head (ONH) configuration of the atrophic phase of non-glaucomatous optic neuropathy when a default set of the ...
ROANOKE, Va. (WDBJ) - As GLP-1 medications continue to grow in popularity for weight loss, a group of eye doctors is urging ...
A deep-learning model trained on optical coherence tomography scans of the optic nerve head reliably distinguished among various types of optic nerve damage, such as glaucoma, non-arteritic anterior ...
A Medicare cohort study of nearly 4 million older patients with type 2 diabetes found 2 in 1000 developed nonarteritic anterior ischemic optic neuropathy (NAION) over a period of more than 3 years.
Researchers found that among semaglutide users, the incidence rate of nonarteritic anterior ischemic optic neuropathy was 14.5 per 100,000 person-years. HealthDay News — For individuals with type 2 ...
About The Study: In this nationwide cohort of U.S. veterans with type 2 diabetes, semaglutide initiators had a 2-fold nonarteritic anterior ischemic optic neuropathy (NAION) risk than sodium-glucose ...
Primary care and emergency medicine clinicians should familiarize themselves with common ophthalmologic conditions that, with timely referral and treatment, may help to improve vision. Ischemic optic ...
An increased risk for nonarteritic anterior ischemic optic neuropathy was seen in association with 2 GLP-1 RAs (hazard ratios, 1.39 and 1.25 for semaglutide and liraglutide, respectively). HealthDay ...
Findings seen for patients with type 2 diabetes during a 5-year period. (HealthDay News) — Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results